U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer ...

U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.

The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...

FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...